We’re always told that drug prescribing is all about a careful balance between risk and benefit. People suffering from severe depression do need help, and occasionally a prescribed antidepressant can be helpful. But new research reveals that doctors...
Remicade was trumpeted as a wonder drug for rheumatoid arthritis and Crohn's disease when licensed for use six years ago.
HRT: Modesty forbids, but we told you so
The Pan European Trial in Adjuvant Colon Cancer-1 (PETACC-1) trial has been halted after preliminary results showed a high death rate from AstraZeneca's new drug, raltitrexed. ...
Methylphenidate (MPH) treatment 'may be associated with unacceptable side effects and risks' (J Clin Psychiatry, 1998; 59 [Suppl 7]: 42-9).
THALIDOMIDE: The Alien of the drug world
YOUR FRIENDLY DRUG DEALER: Yes, it’s the family GP
New research reveals that doctors need to think twice before prescribing antidepressants, and patients should think three times before taking them.
Another anti-inflammatory bites the dust. Another COX-2 inhibitor has been shot down by the FDA. Having spent the last two months reviewing the safety of the COX-2-selective non-steroidal anti-inflammatory drugs (NSAIDs), the US regulatory agency...
A drug for irritable bowel syndrome (IBS) which was linked to the deaths of at least five patients, within nine months of being licensed, may soon be back on the market.
What Doctors Don't Tell You